1. Home
  2. UCTT vs ADMA Comparison

UCTT vs ADMA Comparison

Compare UCTT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultra Clean Holdings Inc.

UCTT

Ultra Clean Holdings Inc.

HOLD

Current Price

$79.80

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$10.82

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCTT
ADMA
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
UCTT
ADMA
Price
$79.80
$10.82
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$75.00
$28.00
AVG Volume (30 Days)
911.6K
9.8M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.60
Revenue
$1,734,500,000.00
$42,219,783.00
Revenue This Year
$19.18
$27.46
Revenue Next Year
$17.36
$22.11
P/E Ratio
N/A
$18.35
Revenue Growth
N/A
43.85
52 Week Low
$18.02
$7.21
52 Week High
$79.58
$25.67

Technical Indicators

Market Signals
Indicator
UCTT
ADMA
Relative Strength Index (RSI) 72.93 44.50
Support Level $23.56 $7.21
Resistance Level N/A $16.48
Average True Range (ATR) 3.70 0.47
MACD 1.09 0.38
Stochastic Oscillator 96.88 87.29

Price Performance

Historical Comparison
UCTT
ADMA

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments: Products and Services. Its principal markets are the Americas, Asia Pacific, and EMEA.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: